Meningitis Cases Associated with Injectable Steroids PDF Print E-mail

The Maryland Department of Health and Mental Hygiene (DHMH), in conjunction with other states, the Centers for Disease Control and Prevention (CDC), and the US Food and Drug Administration (FDA), continues to investigate an association between spinal injections and the development of meningitis as part of a larger multi-state investigation. 

As this investigation continues, the Department will post updates off its home page,  under “Meningitis Cases Associated with Injectable Steroids.”


DHMH continues to urge people who have new or worsening symptoms, including symptoms of meningitis or stroke, following an injection of methylprednisolone acetate from one of the seven Maryland facilities that received the implicated NECC lots to contact their healthcare provider to determine if further evaluation is indicated. Symptoms of meningitis can include fever, headache, neck stiffness, photophobia, nausea, or vomiting. Stroke symptoms can include but are not limited to double vision, slurred speech, weakness on one side of the body, or difficulty walking.


Facilities that have received and pulled from use the affected product are:

Berlin Interventional Pain Management, Berlin, MD

Box Hill Surgery Center, Abingdon, MD

Greenspring Surgery Center, Baltimore, MD

Harford County Ambulatory Surgery Center, Edgewood, MD

Maryland Pain Specialists, Towson, MD

SurgCenter of Bel Air, Bel Air, MD

Zion Ambulatory Center, Baltimore, MD

Last Updated on Wednesday, 14 November 2012 10:27


Maryland urges residents to avoid use of synthetic marijuana, other illcit drugs. Lab-manufactured products often debilitate or kill, are sold as harmless household items.
Baltimore, MD (November 24, 2015) – The State of Maryland is urging residents to not use manufactured products known as synthetic cannabinoids – often called synthetic marijuana or the street names “Spice” and “K2” – or other illicit drugs. The substances have factored into a number of often-tragic incidents across the state.
Commission shares recommendation for Wash. Adventist Hospital relocation. The panel will consider proposal for $336 million project at its Dec. 17 meeting.
Baltimore, MD (November 19, 2015) – The Maryland Health Care Commission released a Recommended Decision in the matter of the proposed relocation of Washington Adventist Hospital (WAH),  a hospital owned and operated by Gaithersburg-based Adventist HealthCare (AHC).  WAH is currently located in Takoma Park (Montgomery County). The proposed site is in the White Oak area of Silver Spring at 12100 Plum Orchard Drive. The site is adjacent to US RT 29 and the ICC MD 200 and is part of the White Oak Science Gateway Master Plan.
State observes “Get Smart about Antibiotics” Week Nov. 16 through 22. Antibiotic resistance is worsened through misuse, overuse of prescriptions.
Baltimore, MD (November 16, 2015) – This week, the Maryland Department of Health and Mental Hygiene joins the U.S. Centers for Disease Control and Prevention, as well as many national and international partners, to observe the eighth annual “Get Smart About Antibiotics Week,” a weeklong initiative to raise awareness of antibiotic resistance and the importance of appropriate antibiotic prescribing and use.
 Lower Shore Health Insurance Assistance Program

           CLICK HERE

MD Cancer Fund 
Web Mastering by